Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085584 (
encephalopathy
)
18,178
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Trafficking protein particle (TRAPP) complexes, which include the
TRAPPC4 protein
, regulate membrane trafficking between lipid organelles in a process termed vesicular tethering.
TRAPPC4
was recently implicated in a recessive neurodevelopmental condition in four unrelated families due to a shared c.454+3A>G splice variant. Here, we report 23 patients from 17 independent families with an early-infantile-onset neurodegenerative presentation, where we also identified the homozygous variant hg38:11:119020256 A>G (NM_016146.5:c.454+3A>G) in
TRAPPC4
through exome or genome sequencing. No other clinically relevant
TRAPPC4
variants were identified among any of over 10,000 patients with neurodevelopmental conditions. We found the carrier frequency of
TRAPPC4
c.454+3A>G was 2.4-5.4 per 10,000 healthy individuals. Affected individuals with the homozygous
TRAPPC4
c.454+3A>G variant showed profound psychomotor delay, developmental regression, early-onset epilepsy, microcephaly and progressive spastic tetraplegia. Based upon RNA sequencing, the variant resulted in partial exon 3 skipping and generation of an aberrant transcript owing to use of a downstream cryptic splice donor site, predicting a premature stop codon and nonsense mediated decay. These data confirm the pathogenicity of the
TRAPPC4
c.454+3A>G variant, and refine the clinical presentation of
TRAPPC4
-related
encephalopathy
.
...
PMID:A relatively common homozygous TRAPPC4 splicing variant is associated with an early-infantile neurodegenerative syndrome. 3290 Nov 38